MuSE
Somatic point mutation caller for tumor-normal paired samples in next-generation sequencing data, developed at the Department of Bioinformatics and Computational Biology at MD Anderson Cancer Center. Based on a Markov substitution model for molecular evolution with a sample-specific error model.
- Founded
- Not disclosed
- Headquarters
- Not disclosed
- Company size
- Not disclosed
- Products tracked
- 1
Products by MuSE
Pricing for MuSE
Contact sales
Contact MuSE for current plans, volume pricing, and enterprise terms.
Trust profile
Security and compliance
No compliance claims have been published for this company.